The novel use and feasibility of hemostatic oxidized regenerated cellulose agent (SurgiGuard^®): multicenter retrospective study.

ABSTRACT:

Background

SurgiGuard^® is an absorbent hemostatic agent based on oxidized regenerated cellulose. The efficacy, effects and safety of SurgiGuard^® are equivalent to existing hemostatic agents in animal experiments. This study was designed to confirm that the use of SurgiGuard^® alone is effective, safe and feasible compared to combination with other hemostatic methods.

Methods

We retrospectively reviewed clinical data from 12 surgery departments in seven tertiary centers in South Korea nationwide. All surgeries were performed between January and December 2018.

Results

A total of 807 patients were enrolled; 447 patients (55.4%) had comorbidities. The rate of major surgery (operative time ≥4 hours) was 44% (n=355 patients). Regarding the ty

SUBMITTER: Rho SY 

PROVIDER: S-EPMC10506122 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature